1. Home
  2. TSLX vs ZLAB Comparison

TSLX vs ZLAB Comparison

Compare TSLX & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

N/A

Current Price

$17.89

Market Cap

1.8B

Sector

Finance

ML Signal

N/A

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

N/A

Current Price

$24.96

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TSLX
ZLAB
Founded
2010
2013
Country
United States
China
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.6B
IPO Year
2011
2017

Fundamental Metrics

Financial Performance
Metric
TSLX
ZLAB
Price
$17.89
$24.96
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$21.61
$49.60
AVG Volume (30 Days)
361.1K
923.4K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
10.82%
N/A
EPS Growth
N/A
38.46
EPS
0.15
N/A
Revenue
N/A
$460,156,000.00
Revenue This Year
N/A
$9.75
Revenue Next Year
$1.20
$26.03
P/E Ratio
$119.07
N/A
Revenue Growth
N/A
15.33
52 Week Low
$16.04
$15.96
52 Week High
$23.65
$34.72

Technical Indicators

Market Signals
Indicator
TSLX
ZLAB
Relative Strength Index (RSI) 42.96 51.52
Support Level $17.20 $16.84
Resistance Level $17.99 $25.28
Average True Range (ATR) 0.35 0.79
MACD -0.12 -0.42
Stochastic Oscillator 13.90 30.05

Price Performance

Historical Comparison
TSLX
ZLAB

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. The company partners with other companies across a variety of industries and provides creative solutions with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: